CDC warns of rapid spread of new COVID-19 JN.1 subvariant amidst holiday travel; drugmakers and physicians experience significant drops in reputation; HHS urges action amidst soaring drop in child enrollment for Medicaid plans.
Emergence of JN.1 Subvariant Raises Concerns as It Becomes Dominant Strain in the US
The CDC alerted the public to the swift ascent of the JN.1 subvariant, now responsible for 20% of new COVID-19 infections in the country, according to CNN. Descended from the previously noted BA.2.86 variant, JN.1 exhibits heightened transmissibility, with estimates indicating its potential to become the leading global variant. The CDC underscores the importance of vaccination, especially as waning immunity and holiday travel contribute to the subvariant's rapid growth.
Americans' Dissatisfaction with Health Care System Grows Since 2010, Analysis Reveals
According to a recent Gallup analysis, Americans' satisfaction with various components of the health care system has declined since 2010, with drugmakers experiencing the most substantial reputational decline, reports Axios. Factors such as the COVID-19 pandemic, escalating health care costs, and the opioid crisis are cited as potential contributors to the diminishing sentiment. The study also highlights a notable drop in satisfaction with physicians, indicating a shift from the goodwill initially felt towards health care professionals at the beginning of the pandemic.
Biden Administration Alerts Governors to Alarming Medicaid Losses Among Children
The Biden administration has issued warnings to governors in 9 states, including Florida, Texas, and Georgia, about significant Medicaid coverage losses among children, according to The New York Times. HHS secretary Xavier Becerra urged leaders to address the issue and expand Medicaid under the Affordable Care Act. The unwinding of a federal policy has resulted in technical glitches and bureaucratic hurdles, causing millions of children to lose health coverage, prompting the administration's more assertive stance.
Study Highlights Significant Increases in Utilization, Spending on DMD Drugs in Medicaid
May 17th 2024The findings add to recent research on the growing utilization, expenditure, and prices of Duchenne muscular dystrophy (DMD) therapies in the current landscape, an area health care policy could potentially address.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Perioperative Nivolumab Boosts NSCLC Survival: CheckMate 77T Trial
May 16th 2024This interim analysis of the CheckMate 77T trial, outcomes were compared between adult patients receiving neoadjuvant nivolumab plus chemotherapy or neoadjuvant chemotherapy plus placebo for resectable non–small cell lung cancer (NSCLC).
Read More